Emergent BioSolutions
EBS
#8133
Rank
HK$2.84 B
Marketcap
HK$55.40
Share price
3.67%
Change (1 day)
-21.51%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2026 (TTM): -HK$26.97

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is -HK$26.99. In 2025 the company made an earnings per share (EPS) of HK$7.45 an increase over its 2024 EPS that were of -HK$28.49.

EPS history for Emergent BioSolutions from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$26.97-461.81%
2025HK$7.45-126.17%
2024-HK$28.49-75.61%
2023-HK$116.79232.21%
2022-HK$35.16-203.46%
2021HK$33.98-25.09%
2020HK$45.36445.28%
2019HK$8.32-15.2%
2018HK$9.81-35.9%
2017HK$15.3069.57%
2016HK$9.02-27.67%
2015HK$12.4865.62%
2014HK$7.5311.63%
2013HK$6.7532.31%
2012HK$5.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.96-122.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$9.93-136.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$25.09-192.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-HK$14.12-47.67%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
HK$4.16-115.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$34.14 26.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$4.94-118.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel